FDA Eases Guidance Spurs AI Health Innovation

The FDA issued new guidance classifying many wearables and health software as "low risk," and companies rapidly launched AI-powered services this month, including Utah-based Doctronic's $4 prescription refill platform and OpenAI's ChatGPT Health waitlist. Anthropic announced EHR-focused Claude features and OpenAI bought startup Torch on January 12; the guidance lowers regulatory barriers, potentially reducing costs and expanding consumer access.